Trials / Completed
CompletedNCT04403555
Ivermectin as a Novel Therapy in COVID-19 Treatment
The Efficacy of Ivermectin in COVID-19 Treatment
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 164 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Efficacy of Ivermectin in COVID-19 treatment
Detailed description
Clinical Study Evaluating the Efficacy of Ivermectin in COVID-19 treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ivermectin | Ivermectin treatment |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2020-10-31
- Completion
- 2020-12-01
- First posted
- 2020-05-27
- Last updated
- 2021-08-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04403555. Inclusion in this directory is not an endorsement.